Reporting Manager
LYNX1 CAPITAL MANAGEMENT LP
Symbol
PASG
Shares outstanding
3,182,163 shares
Disclosed Ownership
623,704 shares
Ownership
20%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 14:01:44 UTC
Date of event
30 Sep 2025
Previous filing
14 Feb 2025

Sponsored

Quoteable Key Fact

"Lynx1 Capital Management LP disclosed 20% ownership in Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG) on 30 Sep 2025."

Quick Takeaways

  • Lynx1 Capital Management LP filed SCHEDULE 13G/A for Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG).
  • Disclosed ownership: 20%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 14 Nov 2025, 14:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
LYNX1 CAPITAL MANAGEMENT LP 20% 623,704 0 623,704 s/ Weston Nichols By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
WESTON NICHOLS 20% 623,704 0 623,704 /s/ Weston Nichols Weston Nichols, Individually